AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Schiffer, CA Anderson, KC Bennett, CL Bernstein, S Elting, LS Goldsmith, M Goldstein, M Hume, H McCullough, JJ McIntyre, RE Powell, BL Rainey, JM Rowley, SD Rebulla, P Troner, MB Wagnon, AH
Citation: Ca. Schiffer et al., Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology, J CL ONCOL, 19(5), 2001, pp. 1519-1538

Authors: Rowley, SD Yu, J Gooley, T Heimfeld, S Holmberg, L Maloney, D Bensinger, WI
Citation: Sd. Rowley et al., Trafficking of CD34(+) cells into the peripheral circulation during collection of peripheral blood stem cells by apheresis, BONE MAR TR, 28(7), 2001, pp. 649-656

Authors: Rowley, SD
Citation: Sd. Rowley, Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs, BONE MAR TR, 28(4), 2001, pp. 315-321

Authors: Rowley, SD Donaldson, G Lilleby, K Bensinger, WI Applebaum, FR
Citation: Sd. Rowley et al., Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation (vol 97, pg 2541, 2001), BLOOD, 98(5), 2001, pp. 1301-1301

Authors: Rowley, SD Donaldson, G Lilleby, K Bensinger, WI Applebaum, FR
Citation: Sd. Rowley et al., Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation, BLOOD, 97(9), 2001, pp. 2541-2548

Authors: Rowley, SD
Citation: Sd. Rowley, Current good manufacturing practices: application to the processing of hematopoietic cell components, CYTOTHERAPY, 2(1), 2000, pp. 59-62

Authors: Flowers, MED Leisenring, W Beach, K Riddell, S Radich, JP Higano, CS Rowley, SD Chauncey, TR Bensinger, WI Sanders, JE Anasetti, C Storb, R Wade, J Appelbaum, FR Martin, PJ
Citation: Med. Flowers et al., Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion forrecurrent chronic myeloid leukemia after bone marrow transplantation, BIOL BLOOD, 6(3A), 2000, pp. 321-326

Authors: Rowley, SD Liang, PS Ulz, L
Citation: Sd. Rowley et al., Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components, BONE MAR TR, 26(7), 2000, pp. 749-757

Authors: Yu, J Leisenring, M Fritschle, W Heimfeld, S Shulman, H Bensinger, WI Holmberg, LA Rowley, SD
Citation: J. Yu et al., Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34(+) cell yield in the apheresis collection, BONE MAR TR, 25(11), 2000, pp. 1157-1164

Authors: Cavallaro, AM Lilleby, K Majolino, I Storb, R Appelbaum, FR Rowley, SD Bensinger, WI
Citation: Am. Cavallaro et al., Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor, BONE MAR TR, 25(1), 2000, pp. 85-89

Authors: Rowley, SD Feng, Z Yadock, D Holmberg, L MacLeod, B Heimfeld, S
Citation: Sd. Rowley et al., Post-thaw removal of DMSO does not completely abrogate infusional toxicityor the need for pre-infusion histamine blockade, CYTOTHERAPY, 1(6), 1999, pp. 439-446

Authors: Rowley, SD MacLeod, B Heimfeld, S Holmberg, L Bensinger, WI
Citation: Sd. Rowley et al., Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC components, CYTOTHERAPY, 1(4), 1999, pp. 311-317

Authors: Rowley, SD
Citation: Sd. Rowley, Welcome to cytotherapy, CYTOTHERAPY, 1(1), 1999, pp. 1-1

Authors: Yu, J Leisenring, W Bensinger, WI Holmberg, LA Rowley, SD
Citation: J. Yu et al., The predictive value of white cell or CD34+cell count in the peripheral blood for timing apheresis and maximizing yield, TRANSFUSION, 39(5), 1999, pp. 442-450

Authors: Rowley, SD Prather, K Bui, KT Appel, M Felt, T Bensinger, WI
Citation: Sd. Rowley et al., Collection of peripheral blood progenitor cells with an automated leukapheresis system, TRANSFUSION, 39(11-12), 1999, pp. 1200-1206

Authors: Martin, PJ Rowley, SD Anasetti, C Chauncey, TR Gooley, T Petersdorf, EW van Burik, J Flowers, MED Storb, R Appelbaum, FR Hansen, JA
Citation: Pj. Martin et al., A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients, BLOOD, 94(7), 1999, pp. 2192-2199
Risultati: 1-16 |